A 2-year longitudinal PBMC gene expression profiling of MS patients receiving interferon-beta 1b predicts therapy outcome

2007 ◽  
Vol 34 (S 2) ◽  
Author(s):  
R Goertsches ◽  
S Möller ◽  
D Koczan ◽  
P Serrano-Fernandez ◽  
HJ Thiesen ◽  
...  
PLoS ONE ◽  
2014 ◽  
Vol 9 (7) ◽  
pp. e102331 ◽  
Author(s):  
Rana Khsheibun ◽  
Tamar Paperna ◽  
Anat Volkowich ◽  
Izabella Lejbkowicz ◽  
Nili Avidan ◽  
...  

2008 ◽  
Vol 10 (4) ◽  
pp. 329-339 ◽  
Author(s):  
Toshihiko Wakabayashi ◽  
Atsushi Natsume ◽  
Yoshio Hashizume ◽  
Masazumi Fujii ◽  
Masaaki Mizuno ◽  
...  

2002 ◽  
Vol 69 ◽  
pp. 135-142 ◽  
Author(s):  
Elena M. Comelli ◽  
Margarida Amado ◽  
Steven R. Head ◽  
James C. Paulson

The development of microarray technology offers the unprecedented possibility of studying the expression of thousands of genes in one experiment. Its exploitation in the glycobiology field will eventually allow the parallel investigation of the expression of many glycosyltransferases, which will ultimately lead to an understanding of the regulation of glycoconjugate synthesis. While numerous gene arrays are available on the market, e.g. the Affymetrix GeneChip® arrays, glycosyltransferases are not adequately represented, which makes comprehensive surveys of their gene expression difficult. This chapter describes the main issues related to the establishment of a custom glycogenes array.


2007 ◽  
Vol 177 (4S) ◽  
pp. 93-93
Author(s):  
Toshiyuki Tsunoda ◽  
Junichi Inocuchi ◽  
Darren Tyson ◽  
Seiji Naito ◽  
David K. Ornstein

2004 ◽  
Vol 171 (4S) ◽  
pp. 198-199 ◽  
Author(s):  
Ximing J. Yang ◽  
Jun Sugimura ◽  
Maria S. Tretiakova ◽  
Bin T. Teh

Sign in / Sign up

Export Citation Format

Share Document